CVS Health is conducting a review of strategic alternatives for the company that may include a potential break-up, The Wall Street Journal’s Lauren Thomas and Anna Wilde Mathews report, citing people with the matter. CVS Health has hired bankers to facilitate the review, which has been ongoing for weeks, though no decision looks “imminent”, the report states.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CVS:
- Stellantis cuts 2024 targets, TPG acquires AT&T’s DirecTV stake: Morning Buzz
- Early notable gainers among liquid option names on September 30th
- Morning Movers: Stellantis skids following FY24 guidance cut
- Barclays sees margin benefits from Humana, CVS Medicare Advantage exits
- Glenview Capital Eyes Turnaround for CVS Health (NYSE:CVS) Amid Financial Strain